Safe drinking with a twist: how limes can help clean water

Limes on sale at a Vietnamese market

Limes on sale at a Vietnamese market

If you grab a beer in Mexico your camarero will wedge a lime in the top. The same simple action, with a dash of sunlight, can be used to treat contaminated water in developing countries. Researchers at the John Hopkins Bloomberg School of Public Health have found that adding lime juice to a solar disinfection method speeds up the removal of harmful bacteria, such as E. coli, significantly faster than by sunlight alone.

Continue reading

ECCMID 2012: Coexistence of infection – NTDs, HIV and STDs

A recurring theme of the NTD sessions at this year’s ECCMID conference was the relationship between NTDs, HIV and STDs. Figures for each seem to overlap, as do some of the physical signs.

Geographical overlap of schistosomiasis and HIV infectionsEach complements the other’s existence. For example, an NTD’s (such as schistosomiasis) symptoms make target areas (in this case epithelium)  vulnerable and as a result ease the path of sexually transmitted disease (STDs) and HIV agents into the body. And with that, the person becomes coinfected by more than one dangerous illness.

The management of one, therefore, should take into account the others’. Here is a summary of what the ECCMID conference highlighted, particularly for schistosomiasis.

Continue reading

ECCMID 2012: Urogenital schistosomiasis

Dr Eyrun Kjetland from the School of Biological and Conservation Sciences at the University of KwaZulu-Natal in South Africa presented current research into urogenital schistosomiasis at this year’s ECCMID conference.

Taking a step back to begin with, she said schistosomiasis itself affects 2 billion people worldwide; 80 million of these show symptoms and just over 30 million receive treatment.

It’s a growing problem in some regions, particularly among travelers and migrants. People become infected with schistosomiasis when worm forms of the snail parasite penetrate their skin during contact with infested water. These then live in blood vessels where they grow and reproduce more schistosomes, or eggs. Eggs either pass through as waste or get trapped in the body, causing immune reactions and progressive damage to organs.

Kjetland described the current situation of one target of the schistosomes – the reproductive system. “In the last two decades,” she said, “after the first six community-based studies on this “gyneacological Schistosoma haematobium”, WHO has recommended that this form of the disease should be referred to as urogenital schistosomiasis.

Below is a summary of key points and issues Kjetland raised during her presentation.

Continue reading

ECCMID 2012: Professor Jonathan Cohen

The European Congress on Clinical Microbiology and Infectious Diseases (ECCMID) is in London this weekend, running from Saturday until Tuesday. One in seven people are there, so follow our twitter feed for live updates on what’s going on.

ECCMID is vast – there are 10,000 attendees – and covers areas from insect bites to complex immunology. I managed to nab this year’s President, Professor Jonathan Cohen, to find out more about this year’s Congress and the largest public health event of the year, the London Olympics and Paralympics. We’d just listened to the 2011 Nobel Laureate in Medicine, Professor Jules A. Hoffman, give a keynote address on phylogenetics. Continue reading

3D sensor for the third D: diagnostic tools for infectious diseases

Last week we reported that the fight against neglected tropical diseases (NTDs) was many-fold – now an addition to the third D, diagnostics, literally lives up to that description. Chemists from the University of Texas at Austin have drawn inspiration from the art of origami to create a three-dimensional paper sensor that could test for diseases such as malaria and HIV for less than 10 pence.

The 3D oPAD sensor is less than 10p a pop

The 3D oPAD sensor is less than 10p a pop

Continue reading

The three D’s: new diagnostic tool for infectious diseases

The fight against neglected tropical diseases is many-fold but whilst there is much talk about drug development and delivery, another integral component of treating NTDs is the third D: diagnostics. It’s all very well having the drugs in the right place at the right time but if you don’t know who needs treating then they are no good.

A new technology unveiled last week could bring faster and more accurate results for detecting diseases in developing countries and is only half a centimetre long.

The readout system including the mini chips

Circuits: The readout system including the 5mm mini chips

Continue reading

Leishmaniasis funding from US Department of Defence in jeopardy

When you think of the people and organisations that usually fund NTD research, the US Department of Defence (DOD) isn’t the first one that springs to mind. Since the first Gulf War in the 1990s, the DOD has been trickling a small (relative to some of their other projects) but still significant amount of funding into leishmaniasis research.
Leishmaniasis is endemic in the Middle East, including Iraq and Afghanistan. In 2003, contracting leishmaniasis whilst on tour meant a one-way trip back to the US. In 2006, there were 1287 cases, with each soldier contracting leishmaniasis losing an average of 60 duty days.
DOD budgets show various amounts of funding for leishmaniasis projects, including one of a new skin treatment for the lesions the disease causes, and another for use of medical lasers to treat the lesions. In a report on the Gulf War, DOD spending on leishmaniasis between 1994 and 1998 adds up to just under $5m.The US Military has at times over the past century been at the forefront of reseach into dengue and typhoid fever, malaria, and HIV.
These are treatments that are developed for military personnel in war zones. They need to be transportable, effective in areas with only basic infrastructure and ideally without highly specialised medical personnel. And so, by saving money in defence, the US is simultaneously developing treatments and diagnostic tools that could be ideal for the elimination of the disease in civilians.
In 2008, the DOD accounted for 24% of all US federal spending on leishmaniasis. In 2012, that figure looks set to fall.  As Capitol Hill battles over spending, military research into diseases such as leishmaniasis could be cut, not only jeopardising soldier’s lives, but slowing the global war against NTDs.